Inventor · disambiguated record
Shinji Nakamura
Also filed as: NAKAMURA SHINJI
19 granted patents·7 pending applications·120 citations·filing 1976–2024
94Inventor score
Files withTAKEDA PHARMACEUTICALS CO18TAKEDA PHARMACEUTICAL4KORI MASAKUNI2FUKUMOTO SHOJI1SUMITOMO CHEMICAL CO1
Top patents by PatentIndex Score
26 records- 0195US8575154B2Heterocyclic compound and use thereofKORI MASAKUNI·Filed 2011·Granted Nov 5, 2013·31 cites·2 claims
- 0292US9884875B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 6, 2018·7 cites·1 claims
- 0391US9499568B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 22, 2016·8 cites·17 claims
- 0489US10807987B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Oct 20, 2020·5 cites·8 claims
- 0589US10654874B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 19, 2020·4 cites·3 claims
- 0689US9150591B2Heterocyclic compound and use thereofKORI MASAKUNI·Filed 2011·Granted Oct 6, 2015·10 cites·29 claims
- 0789US2024360156A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0888US9527807B2Sulfonamide derivative and use thereofFUKUMOTO SHOJI·Filed 2012·Granted Dec 27, 2016·26 cites·11 claims
- 0984US11702419B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jul 18, 2023·1 cites·18 claims
- 1084US11279713B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Mar 22, 2022·1 cites·5 claims
- 1183US8778934B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2013·Granted Jul 15, 2014·3 cites·2 claims
- 1280US8916551B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2013·Granted Dec 23, 2014·2 cites·2 claims
- 1378US11407748B2Substituted pyrido[1,2-a]pyrimidines and pyrazino[1,2-a]pyrimidines for enhancing AMPA receptor functionTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Aug 9, 2022·1 cites·12 claims
- 1476US11447488B2Heterocyclic compoundsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 20, 2022·1 cites·9 claims
- 1572US9493484B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Nov 15, 2016·2 cites·9 claims
- 1670US11939327B2Heterocyclic compoundsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Mar 26, 2024·0 cites·26 claims
- 1769US9469637B2Nitrogenated heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 18, 2016·1 cites·2 claims
- 1868US9527841B2Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Dec 27, 2016·2 cites·10 claims
- 1967US2018162875A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2017·Application pending·0 cites
- 2067US2015073137A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 2165US4096184AProcess for preparing acid amidesSUMITOMO CHEMICAL CO·Filed 1976·Granted Jun 20, 1978·15 cites·16 claims
- 2262US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2350US2023348435A11-((1h-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2h-imidazol-2-one derivatives and related compounds as gpr139 antagonists for the treatment of e.g. depressionTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2444US10017508B2Nitrogenated heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 10, 2018·0 cites·11 claims
- 2544US2016159808A1Heterocyclic compoundTAKEDA PHARMACEUTICAL·Filed 2014·Application pending·0 cites
- 2644US2016264536A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shinji Nakamura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →